Two Sigma Advisers’s ResMed RMD Stock Holding History

Two Sigma Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,400	Closed	-$9.97M	–	1709
2025 Q4	$9.97M	Buy	41,400 +33,200	+405%	+$8.49M	0.02%	544
2025 Q3	$2.24M	Buy	+8,200	New	+$2.24M	﹤0.01%	1092
2024 Q4	–	Sell	-900	Closed	-$220K	–	2493
2024 Q3	$220K	Sell	900 -3,600	-80%	-$804K	﹤0.01%	2034
2024 Q2	$861K	Sell	4,500 -1,500	-25%	-$304K	﹤0.01%	1629
2024 Q1	$1.19M	Sell	6,000 -377,900	-98%	-$69.2M	﹤0.01%	1495
2023 Q4	$66M	Sell	383,900 -313,700	-45%	-$48.2M	0.15%	142
2023 Q3	$103M	Buy	697,600 +610,500	+701%	+$110M	0.26%	93
2023 Q2	$19M	Buy	87,100 +64,500	+285%	+$14.4M	0.05%	316
2023 Q1	$4.95M	Buy	+22,600	New	+$4.9M	0.01%	813
2022 Q4	–	Sell	-9,000	Closed	-$1.97M	–	2663
2022 Q3	$1.97M	Sell	9,000 -6,800	-43%	-$1.55M	0.01%	1179
2022 Q2	$3.31M	Sell	15,800 -2,100	-12%	-$447K	0.01%	954
2022 Q1	$4.34M	Sell	17,900 -128,800	-88%	-$31.2M	0.01%	858
2021 Q4	$38.2M	Sell	146,700 -132,700	-47%	-$34.4M	0.1%	187
2021 Q3	$73.6M	Buy	+279,400	New	+$76.4M	0.19%	110
2020 Q4	–	Sell	-3,300	Closed	-$566K	–	2555
2020 Q3	$566K	Sell	3,300 -4,600	-58%	-$849K	﹤0.01%	1755
2020 Q2	$1.52M	Sell	7,900 -7,800	-50%	-$1.28M	﹤0.01%	1363
2020 Q1	$2.31M	Sell	15,700 -34,100	-68%	-$5.43M	0.01%	1043
2019 Q4	$7.72M	Sell	49,800 -3,900	-7%	-$562K	0.02%	679
2019 Q3	$7.25M	Buy	+53,700	New	+$7.04M	0.02%	645
2018 Q4	–	Sell	-33,519	Closed	-$3.87M	–	2439
2018 Q3	$3.87M	Buy	33,519 +14,000	+72%	+$1.53M	0.01%	926
2018 Q2	$2.02M	Buy	19,519 +14,000	+254%	+$1.42M	0.01%	1286
2018 Q1	$543K	Buy	+5,519	New	+$522K	﹤0.01%	1784
2017 Q2	–	Sell	-28,419	Closed	-$2.04M	–	2374
2017 Q1	$2.04M	Sell	28,419 -70,100	-71%	-$4.84M	0.01%	1244
2016 Q4	$6.11M	Buy	98,519 +8,000	+9%	+$490K	0.02%	647
2016 Q3	$5.87M	Sell	90,519 -45,700	-34%	-$3.04M	0.03%	594
2016 Q2	$8.61M	Sell	136,219 -51,000	-27%	-$3.01M	0.04%	402
2016 Q1	$10.8M	Buy	187,219 +183,191	+4,548%	+$10.4M	0.06%	327
2015 Q4	$216K	Sell	4,028 -132,911	-97%	-$7.49M	﹤0.01%	1638
2015 Q3	$6.98M	Buy	136,939 +119,511	+686%	+$6.43M	0.04%	393
2015 Q2	$982K	Buy	+17,428	New	+$1.1M	0.01%	1132
2014 Q3	–	Sell	-4,919	Closed	-$249K	–	2615
2014 Q2	$249K	Sell	4,919 -128,900	-96%	-$6.39M	﹤0.01%	2124
2014 Q1	$5.98M	Buy	+133,819	New	+$6.01M	0.05%	381
2013 Q3	–	Sell	-4,904	Closed	-$222K	–	2338
2013 Q2	$222K	Buy	+4,904	New	+$233K	﹤0.01%	1915

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers's RMD Position: Q1 2026 in Review

Two Sigma Advisers sold out of ResMed (RMD) in Q1 2026, closing a stake of 41,400 shares — an estimated $9.97M sold.

Two Sigma Advisers first reported a position in RMD in Q2 2013 and held it in 33 quarters. The position peaked at $103M in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Two Sigma Advisers reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 41,400 ResMed shares in Q1 2026, an estimated $9.97M.
Two Sigma Advisers first reported a position in ResMed in Q2 2013 and held it in 33 quarters.
Two Sigma Advisers's ResMed position peaked at $103M in Q3 2023.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.